203 related articles for article (PubMed ID: 20429865)
1. The human trypanolytic factor: a drug shaped naturally.
Vanhamme L
Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
[TBL] [Abstract][Full Text] [Related]
2. [Molecular dialogue between African trypanosomes and humans].
Pays E
Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
[TBL] [Abstract][Full Text] [Related]
3. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.
Capewell P; Cooper A; Clucas C; Weir W; Macleod A
Parasitology; 2015 Feb; 142 Suppl 1(Suppl 1):S108-19. PubMed ID: 25656360
[TBL] [Abstract][Full Text] [Related]
4. Mutual self-defence: the trypanolytic factor story.
Pays E; Vanhollebeke B
Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
[TBL] [Abstract][Full Text] [Related]
5. The molecular arms race between African trypanosomes and humans.
Pays E; Vanhollebeke B; Uzureau P; Lecordier L; Pérez-Morga D
Nat Rev Microbiol; 2014 Aug; 12(8):575-84. PubMed ID: 24975321
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection.
Cuypers B; Lecordier L; Meehan CJ; Van den Broeck F; Imamura H; Büscher P; Dujardin JC; Laukens K; Schnaufer A; Dewar C; Lewis M; Balmer O; Azurago T; Kyei-Faried S; Ohene SA; Duah B; Homiah P; Mensah EK; Anleah F; Franco JR; Pays E; Deborggraeve S
mBio; 2016 Apr; 7(2):e02198-15. PubMed ID: 27073096
[TBL] [Abstract][Full Text] [Related]
7. The trypanolytic factor of human serum.
Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
[TBL] [Abstract][Full Text] [Related]
8. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
Lecordier L; Vanhollebeke B; Poelvoorde P; Tebabi P; Paturiaux-Hanocq F; Andris F; Lins L; Pays E
PLoS Pathog; 2009 Dec; 5(12):e1000685. PubMed ID: 19997494
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Trypanosoma brucei gambiense resistance to human serum.
Uzureau P; Uzureau S; Lecordier L; Fontaine F; Tebabi P; Homblé F; Grélard A; Zhendre V; Nolan DP; Lins L; Crowet JM; Pays A; Felu C; Poelvoorde P; Vanhollebeke B; Moestrup SK; Lyngsø J; Pedersen JS; Mottram JC; Dufourc EJ; Pérez-Morga D; Pays E
Nature; 2013 Sep; 501(7467):430-4. PubMed ID: 23965626
[TBL] [Abstract][Full Text] [Related]
10. A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
Cooper A; Capewell P; Clucas C; Veitch N; Weir W; Thomson R; Raper J; MacLeod A
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004903. PubMed ID: 27494254
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus.
Lecordier L; Uzureau P; Tebabi P; Brauner J; Benghiat FS; Vanhollebeke B; Pays E
Mol Microbiol; 2015 Aug; 97(3):397-407. PubMed ID: 25899052
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of serum resistance associated protein in Trypanosoma brucei rhodesiense.
Milner JD; Hajduk SL
Mol Biochem Parasitol; 1999 Nov; 104(2):271-83. PubMed ID: 10593181
[TBL] [Abstract][Full Text] [Related]
13. Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis.
Thomson R; Finkelstein A
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2894-9. PubMed ID: 25730870
[TBL] [Abstract][Full Text] [Related]
14. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
[TBL] [Abstract][Full Text] [Related]
15. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
Nat Med; 2006 May; 12(5):580-4. PubMed ID: 16604085
[TBL] [Abstract][Full Text] [Related]
16. Drug transport and drug resistance in African trypanosomes.
Mäser P; Lüscher A; Kaminsky R
Drug Resist Updat; 2003 Oct; 6(5):281-90. PubMed ID: 14643298
[TBL] [Abstract][Full Text] [Related]
17. Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei.
Kieft R; Stephens NA; Capewell P; MacLeod A; Hajduk SL
Mol Biochem Parasitol; 2012 May; 183(1):8-14. PubMed ID: 22226682
[TBL] [Abstract][Full Text] [Related]
18. Localization of serum resistance-associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei.
Bart JM; Cordon-Obras C; Vidal I; Reed J; Perez-Pastrana E; Cuevas L; Field MC; Carrington M; Navarro M
Cell Microbiol; 2015 Oct; 17(10):1523-35. PubMed ID: 25924022
[TBL] [Abstract][Full Text] [Related]
19. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
20. Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
Capewell P; Veitch NJ; Turner CM; Raper J; Berriman M; Hajduk SL; MacLeod A
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1287. PubMed ID: 21909441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
